These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7231198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ, Peters JR, Frantz ID, Hunninghake DB.
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH, Smith FR, Berns L, Eder HA, Goodman DS.
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ, Linden CV, O'Connell MJ, Heilman J.
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [Abstract] [Full Text] [Related]

  • 7. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG, Haft GK, Juliano J.
    Atherosclerosis; 1976 Apr; 23(3):413-27. PubMed ID: 178325
    [Abstract] [Full Text] [Related]

  • 8. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA, Heimann KW.
    S Afr Med J; 1975 Jul 19; 49(31):1252-6. PubMed ID: 168650
    [Abstract] [Full Text] [Related]

  • 9. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan 19; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 10. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L, Nowicka G, Szostak WB, Naruszewicz M.
    Atherosclerosis; 1987 Feb 19; 63(2-3):203-9. PubMed ID: 3827981
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 13. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
    Weisweiler P, Merk W, Jacob B, Schwandt P.
    Eur J Clin Pharmacol; 1986 Jul 01; 30(2):191-4. PubMed ID: 3709644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
    Kuo PT, Hayase K, Kostis JB, Moreyra AE.
    Circulation; 1979 Feb 01; 59(2):199-211. PubMed ID: 215338
    [Abstract] [Full Text] [Related]

  • 16. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA, Krehbiel P, Decoursey S, Jackson B, Chernoff SB, Pitterman A, Garty M.
    Ann Intern Med; 1984 Apr 01; 100(4):477-82. PubMed ID: 6367578
    [Abstract] [Full Text] [Related]

  • 17. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ.
    N Engl J Med; 1981 Jan 29; 304(5):251-8. PubMed ID: 7003391
    [Abstract] [Full Text] [Related]

  • 18. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P.
    Metabolism; 1989 Mar 29; 38(3):271-4. PubMed ID: 2918846
    [Abstract] [Full Text] [Related]

  • 19. Plasma and lipoprotein lipid responses to four hypolipid drugs.
    Hazzard WR, Wahl PW, Gagne C, Applebaum-Bowden D, Warnick GR, Albers JJ.
    Lipids; 1984 Feb 29; 19(2):73-9. PubMed ID: 6708754
    [Abstract] [Full Text] [Related]

  • 20. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP, Helve E, Karjalainen K, Tarkkanen A, Tikkanen MJ.
    Atherosclerosis; 1990 May 29; 82(1-2):85-95. PubMed ID: 2360923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.